The robotic assisted surgery systems market encompasses an array of technologically advanced surgical platforms that integrate robotics, imaging, and navigation systems to assist surgeons in performing minimally invasive procedures with increased precision and control. These systems are designed to enhance surgical capabilities, improve patient outcomes, and minimize the invasiveness of traditional surgical techniques. The noteworthy benefits of robotic assisted surgery systems include enhanced dexterity, three-dimensional visualization, and tremor filtration, allowing surgeons to perform complex procedures with superior accuracy and maneuverability. These systems often enable them to access difficult-to-reach anatomical areas, leading to reduced trauma and faster patient recovery times. Additionally, the integration of robotics in surgeries minimizes the risk of complications and lowers the need for blood transfusions, ultimately contributing to improved post-operative outcomes.
The increasing number of research studies exploring the benefits and capabilities of robotically assisted operations is anticipated to fuel market progress in the coming years. In September 2022, a team from the Graduate School of Medical Sciences, Nagoya City University (NCU), conducted a study comparing robotic-assisted, fluoroscopic-guided, ultrasound-guided renal access for percutaneous nephrolithotomy. The study's findings demonstrate the safety and ease of use of revolutionary robotic devices, which may lessen the training burden on surgeons and enable more hospitals to perform PCNL procedures. This method, which uses robotics driven by artificial intelligence, may open a door to the automation of comparable surgical interventions, in turn, speeding up the process and lowering the risk of complications.
A rise in chronic disease cases and the growing popularity of minimally invasive surgeries further favor the robotic assisted surgical systems market. According to news released by The Hindu in August 2022, Apollo Health City in Hyderabad, India, has completed more than 500 robotically assisted gynecological procedures. In November 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, and Venkateshwar Hospital in Delhi announced the completion of the first urological treatment in north India with the Hugo robotic assisted surgery (RAS) system.
On the other hand, the high cost of robotic surgical systems hampers the financial viability and operational sustainability of healthcare providers. While these systems offer advantages such as enhanced precision, minimal invasiveness, and reduced patient recovery times, the substantial upfront investment and ongoing maintenance costs necessitate careful financial planning and resource allocation for healthcare facilities. Additionally, the need for specialized training and certification of surgical personnel to operate these systems adds further operational costs, impacting the overall affordability and practicality of integrating robotic surgery into existing clinical practices. The cost burden associated with robotic surgical systems has the potential to influence healthcare reimbursement models and coverage decisions. Reimbursement rates for procedures performed with robotic assistance may vary, and coverage by insurance providers could affect the economic rationale for adopting these technologies. This creates a complex landscape where healthcare facilities need to weigh the clinical advantages of robotic surgery against the financial implications, potentially affecting the pace and scale of adoption across different healthcare systems.
The robotic assisted surgery systems market is segmented on the basis of product type, application, and end user. Based on product type, the market is divided into systems, instruments and accessories, and services. By application, the robotic assisted surgery systems market is segmented into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The market, based on end user, is classified into hospitals, ambulatory surgery centers, and other end users. In terms of geography, the robotic assisted surgery systems market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Based on product type, the surgical robot segment held a substantial revenue share of the robotic assisted surgery systems market in 2022. The need for surgical robots to perform precise and accurate procedures is predicted to increase due to the surging global incidence of cardiovascular and cancer disorders. The US is expected to report 1.9 million new cancer cases in 2023, according to the American Cancer Society's Cancer Statistics 2023. As per the Australian Institute of Health and Welfare's (AIHW) 2021 report, the estimated new cases of cancer in Australia in 2021 were 150,800. The March 2022 report from the Australian Bureau of Statistics states that 4.0% of Australians, or 1.0 million people, were estimated to have heart disease in 2021.
Based on application, the robot-assisted surgical systems market is classified into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The neurology sector is expected to record the fastest CAGR during 2022–2030. The increasing usage of surgical robots in general surgeries and the benefits they offer over conventional surgical methods benefit the overall market. Furthermore, improvements in technology and the successful results of robotic neurosurgery are anticipated to propel the expansion of the robot-assisted surgical systems market in the coming years. According to SS Innovations Interventional Inc., approximately 1.6 million robotic surgeries were performed globally in 2020.
By end user, the robot-assisted surgical systems market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospital segment dominated the market in 2022 and is anticipated to register a high CAGR during 2022–2030. The growth of the market for hospitals segment is ascribed to rising healthcare costs across several economies. Hospitals provide superior quality of care by utilizing the latest robotic assisted surgical equipment. Moreover, physicians and surgeons prefer robot-assisted systems. The use of robot-assisted operations in overall surgical procedures surged multifold from 1.8% in 2013 to 15.1% in 2019, according to a paper published in the JAMA network.
Based on geography, the robotic assisted surgery systems market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of this market. The market progress in this region is attributed to the growing use of automated surgical instruments and the adoption of next-generation healthcare systems in the US. Furthermore, the lack of surgeons and medical professionals in the US compared to the patient population is projected to benefit the market for robot-assisted surgical systems. The increased prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease propels the demand for robot-assisted surgical systems in the US.
The growing popularity of minimally invasive procedures as opposed to conventional operations favors the robotic assisted surgery systems market. In December 2022, Hugo extended the clinical trials of its robotic assisted surgery (RAS) systems in the US by enrolling their first patient, according to Medtronic plc. Further, in 2022,a doctor at Duke University Hospital in Durham, North Carolina, carried out the robotic assisted prostatectomy procedure.
The Asia Pacific robotic assisted surgical systems market is expected to grow at the fastest CAGR during 2022–2030 owing to the growing patient population and rising use of sophisticated automated surgical instruments. Additionally, expanding contemporary healthcare facilities and increasing public awareness of the advantages of cutting-edge medical technologies are anticipated to benefit the market growth in this region in the future. Governments of countries in Asia Pacific are making attempts to establish sophisticated healthcare infrastructure, which is drawing international businesses to invest in the establishment of automated instrument development facilities in this region. China holds the largest share of the robot-assisted surgical systems market in Asia Pacific, and India is expected to record the highest CAGR during 2022–2030. Companies in the surgical robotics business in China have shortened their time to market by taking advantage of a special approval pathway that expedites regulatory approval for innovative medical products. Moreover, an increasingly large number of medtech firms specializing in surgical robotics are emerging in the country. In recent years, JianJia Robots and Hurwa entered the Chinese market to develop surgical robotics solutions alongside TINAVI, a domestic company specializing in orthopedic surgical robots. Beijing reimburses TINAVI robot-assisted surgeries for the spine, hip, and knee.
The regional trends and factors influencing the Robotic Assisted Surgery Systems Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Robotic Assisted Surgery Systems Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 7,831.93 Million |
| Market Size by 2030 | US$ 23,816.80 Million |
| Global CAGR (2022 - 2030) | 14.9% |
| Historical Data | 2020-2022 |
| Forecast period | 2022-2030 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Robotic Assisted Surgery Systems Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Robotic Assisted Surgery Systems Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Various initiatives taken by key players operating in the global robotic assisted surgery systems market are listed below:
Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc., SRI International Inc., Accuray Incorporated, Renishaw PLC, Medtronic PLC, Brainlab, Smith & Nephew PLC, Globus Medical, and Zimmer Biomet are among the prominent players in the robotic assisted surgery systems market. These companies focus on expanding their offerings to meet the growing consumer demand worldwide. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.
The List of Companies - Robotic Assisted Surgery Systems Market
The robotic assisted surgery systems market has major market players, including Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc., SRI International Inc., Accuray Incorporated, Renishaw PLC, Medtronic PLC, Brainlab, Smith & Nephew PLC, Globus Medical, and Zimmer Biomet.
Based on product type, the surgical robot segment held a substantial revenue share of the robotic assisted surgery systems market in 2022. The need for surgical robots to perform precise and accurate procedures is predicted to increase due to the surging global incidence of cardiovascular and cancer disorders. The US is expected to report 1.9 million new cancer cases in 2023, according to the American Cancer Society's Cancer Statistics 2023. As per the Australian Institute of Health and Welfare's (AIHW) 2021 report, the estimated new cases of cancer in Australia in 2021 were 150,800. The March 2022 report from the Australian Bureau of Statistics states that 4.0% of Australians, or 1.0 million people, were estimated to have heart disease in 2021.
Growing preference for robotically assisted treatments, rising inclination toward minimally invasive surgeries, and the increasing number of product launches are the key factors driving the robotic assisted surgery systems market progress. However, the stringent regulatory processes and high cost of devices hinder the robotic assisted surgery systems market growth.
The robotic assisted surgery systems market was valued at US$ 7,831.93 million in 2022.
The robotic assisted surgery systems market is expected to be valued at US$ 23,816.80 million in 2030.
The robotic assisted surgery systems market encompasses an array of technologically advanced surgical platforms that integrate robotics, imaging, and navigation systems to assist surgeons in performing minimally invasive procedures with increased precision and control. These systems are designed to enhance surgical capabilities, improve patient outcomes, and minimize the invasiveness of traditional surgical techniques.
Based on application, the robot-assisted surgical systems market is classified into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The neurology sector is expected to record the fastest CAGR during 2022–2030. The increasing usage of surgical robots in general surgeries and the benefits they offer over conventional surgical methods benefit the overall market. Furthermore, improvements in technology and the successful results of robotic neurosurgery are anticipated to propel the expansion of the robot-assisted surgical systems market in the coming years. According to SS Innovations Interventional Inc., approximately 1.6 million robotic surgeries were performed globally in 2020.